FDA committee recommends Pfizer vaccine, clearing way for emergency use authorization

December 10, 2020

    A U.S. Food and Drug Administration advisory committee has voted to recommend the Pfizer coronavirus vaccine, all but clearing the way for landmark approval in a months-long effort to turn the tide of the pandemic.

    The decision came as expected Thursday in a 17-4 vote from the FDA’s Vaccines and Related Biological Products Advisory Committee. One committee member abstained. While the agency does not have to follow the committee’s vote, it is fully expected officials will do and fast track the vaccine for distribution with emergency use authorization.

    For the Pfizer vaccine in particular, major distribution hurdles await.

    The doses must be stores in unbelievably cold temperatures at around -70°C to remain active.

    This is a developing story. Check back for updates.

    Follow RADIO.COM
    Facebook | Twitter | Instagram